New antifungals drugs, new approaches and vaccines

Drupal spam blocked by CleanTalk.
Title Antifungal name Trial phase Datesort ascending
Pharmacokinetics of the Novel Echinocandin, CD101, in Multiple Animal Species. Biafungin (CD101) 27 Mar 2017
Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis. Ibrexafungerp (SCY-078, MK-3118) Phase 2 27 Mar 2017
Trans-ungual Delivery of AR-12, a Novel Antifungal Drug. AR-12 13 Mar 2017
In vitro and in vivo antifungal profile of a novel and long acting inhaled azole, PC945, on Aspergillus fumigatus infection. PC945 13 Mar 2017
Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested Against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY (2014) Antifungal Surveillance Program. Biafungin (CD101) 15 Feb 2017
Special Issue: Novel Antifungal Drug Discovery General articles 15 Feb 2017
ram1 gene, encoding a subunit of farnesyltransferase, contributes to growth, antifungal susceptibility to amphotericin B of Aspergillus fumigatus. Manumycin A 4 Feb 2017
Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults. Biafungin (CD101) 23 Jan 2017
Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties. Biafungin (CD101) 23 Jan 2017
Discovery of a new antifungal agent ASP2397 using a silkworm model of Aspergillus fumigatus infection ASP2397 (VL-2397) 17 Jan 2017

Pages